CreativeMedical_IR
$CELZ has built intellectual property across multiple areas of its regenerative medicine and immunotherapy portfolio, creating protection around technologies being developed across different programs and indications.
For a clinical-stage company, that IP can do more than protect innovation. It can support multiple paths forward-from advancing programs internally to potential licensing, partnerships, and other strategic opportunities.
Technology → Intellectual Property → Multiple Paths to Potential Value
That means the CELZ story isn’t tied to a single program or a single development path. As its technologies advance, the IP behind them can help expand the ways those assets may create value over time.
2
3
